Erlend B. Smeland's group

Publications published since 1984 or in press from Lymphomas & lymphocyte biology

173 publications found

Publications 2010

1. Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R (2010)
   Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
   Cell, 142 (5), 699-713
   PubMed 20813259
2. Committee for Advanced Therapies (CAT), CAT Scientific Secretariat, Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Anc?ns J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS, Moraru AS, Turcáni P, Zorec R, Ruiz S, Akerblom L, Narayanan G, Kent A, Bignami F, Dickson JG, Niederwieser D, Figuerola-Santos MA, Reischl IG, Beuneu C, Georgiev R, Vassiliou M, Pychova A, Clausen M, Methuen T, Lucas S, Schüssler-Lenz M, Kokkas V, Buzás Z, MacAleenan N, Galli MC, Lin? A, Gulbinovic J, Berchem G, Fraczek M, Menezes-Ferreira M, Vilceanu N, Hrubisko M, Marinko P, Timón M, Cheng W, Crosbie GA, Meade N, di Paola ML, VandenDriessche T, Ljungman P, D'Apote L, Oliver-Diaz O, Büttel I, Celis P (2010)
   Challenges with advanced therapy medicinal products and how to meet them
   Nat Rev Drug Discov, 9 (3), 195-201
   PubMed 20190786
3. Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB, Kohlhammer H, Lamy L, Zhao H, Yang Y, Xu W, Shaffer AL, Wright G, Xiao W, Powell J, Jiang JK, Thomas CJ, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Johnson NA, Rimsza LM, Campo E, Jaffe ES, Wilson WH, Delabie J, Smeland EB, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pierce SK, Staudt LM (2010)
   Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
   Nature, 463 (7277), 88-92
   PubMed 20054396
4. Eide MB, Liestøl K, Lingjærde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
   Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
   Blood, 116 (9), 1489-97
   PubMed 20505157
5. Smeland EB, Vartdal F, Wisløff F (2010)
   [Close cooperation, but not oversteering]
   Tidsskr Nor Laegeforen, 130 (6), 590-1
   PubMed 20348990
6. Smeland EB, Vartdal F, Wisløff F (2010)
   [Leadership and academic competence]
   Tidsskr Nor Laegeforen, 130 (6), 591
   PubMed 20348994

Publications 2009

1. Holte H, Kvaløy S, Delabie J, Trøen G, Smeland EB (2009)
   [Molecular diagnosis of malignant lymphomas]
   Tidsskr Nor Laegeforen, 129 (22), 2352-6
   PubMed 19935935
2. Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009)
   Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion
   Blood, 114 (16), 3431-8
   PubMed 19641184
3. Hystad ME, Myklebust JH, Bo TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt L, Smeland EB (2009)
   Characterization of early stages of human B cell development by gene expression profiling (vol 179, pg 3662, 2007)
   J. Immunol., 182 (9), 5882
4. O'Riain C, O'Shea DM, Yang Y, Le Dieu R, Gribben JG, Summers K, Yeboah-Afari J, Bhaw-Rosun L, Fleischmann C, Mein CA, Crook T, Smith P, Kelly G, Rosenwald A, Ott G, Campo E, Rimsza LM, Smeland EB, Chan WC, Johnson N, Gascoyne RD, Reimer S, Braziel RM, Wright GW, Staudt LM, Lister TA, Fitzgibbon J (2009)
   Array-based DNA methylation profiling in follicular lymphoma
   Leukemia, 23 (10), 1858-66
   PubMed 19587707

Publications 2008

1. Døsen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E (2008)
   Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape
   Int J Cancer, 123 (12), 2759-66
   PubMed 18798273
2. Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008)
   Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
   Science, 319 (5870), 1676-9
   PubMed 18323416
3. Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project (2008)
   Stromal gene signatures in large-B-cell lymphomas
   N Engl J Med, 359 (22), 2313-23
   PubMed 19038878
4. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008)
   Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
   Proc Natl Acad Sci U S A, 105 (36), 13520-5
   PubMed 18765795
5. O'Shea D, O'Riain C, Taylor C, Waters R, Carlotti E, Macdougall F, Gribben J, Rosenwald A, Ott G, Rimsza LM, Smeland EB, Johnson N, Campo E, Greiner TC, Chan WC, Gascoyne RD, Wright G, Staudt LM, Lister TA, Fitzgibbon J (2008)
   The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
   Blood, 112 (8), 3126-9
   PubMed 18628487

Publications 2007

1. Cabezón T, Celis JE, Skibshøj I, Klingelhöfer J, Grigorian M, Gromov P, Rank F, Myklebust JH, Maelandsmo GM, Lukanidin E, Ambartsumian N (2007)
   Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer
   Int J Cancer, 121 (7), 1433-44
   PubMed 17565747
2. Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB (2007)
   Characterization of early stages of human B cell development by gene expression profiling
   J Immunol, 179 (6), 3662-71
   PubMed 17785802
3. Lenz G, Nagel I, Siebert R, Roschke AV, Sanger W, Wright GW, Dave SS, Tan B, Zhao H, Rosenwald A, Muller-Hermelink HK, Gascoyne RD, Campo E, Jaffe ES, Smeland EB, Fisher RI, Kuehl WM, Chan WC, Staudt LM (2007)
   Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma
   J Exp Med, 204 (3), 633-43
   PubMed 17353367
4. Nygren MK, Døsen G, Hystad ME, Stubberud H, Funderud S, Rian E (2007)
   Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines
   Br J Haematol, 136 (3), 400-13
   PubMed 17156404
5. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH (2007)
   Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
   Eur J Immunol, 37 (10), 2937-48
   PubMed 17899540
6. Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM (2007)
   Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival
   Blood, 109 (11), 4599-606
   PubMed 17299095

Publications 2006

1. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Müller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project (2006)
   Molecular diagnosis of Burkitt's lymphoma
   N Engl J Med, 354 (23), 2431-42
   PubMed 16760443
2. Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB, Rian E (2006)
   BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
   Exp Hematol, 34 (1), 72-81
   PubMed 16413393
3. Sivertsen EA, Galteland E, Mu D, Holte H, Meza-Zepeda L, Myklebost O, Patzke S, Smeland EB, Stokke T (2006)
   Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas
   Leukemia, 20 (3), 539-42
   PubMed 16437153
4. Sivertsen EA, Hystad ME, Gutzkow KB, Døsen G, Smeland EB, Blomhoff HK, Myklebust JH (2006)
   PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells
   Br J Haematol, 135 (1), 117-28
   PubMed 16965383

Publications 2005

1. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V, Burek C, Ott G, Puig X, Yang L, Lopez-Guillermo A, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Gascoyne RD, Connors JM, Grogan TM, Braziel R, Fisher RI, Smeland EB, Kvaloy S, Holte H, Delabie J, Simon R, Powell J, Wilson WH, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Campo E, Rosenwald A, Lymphoma/Leukemia Molecular Profiling Project (2005)
   Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction
   Blood, 106 (9), 3183-90
   PubMed 16046532
2. Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T (2005)
   Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas
   Leukemia, 19 (12), 2313-23
   PubMed 16193090
3. Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH (2005)
   BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
   BMC Immunol, 6 (1), 9
   PubMed 15877825
4. Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
   Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
   Oncogene, 24 (7), 1159-73
   PubMed 15580290
5. Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J (2005)
   PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor
   J Pathol, 206 (3), 312-9
   PubMed 15892171
6. Van Thanh D, Sivertsen E, Moe JF, Jorstad I (2005)
   Email access via mobile phone
   WiMob'2005: IEEE International Conference on Wireless and Mobile Computing, Networking and Communications, Vol, 4 Proceedings, 145-150

Publications 2004

1. Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, Chan WC, Fisher RI, Braziel RM, Rimsza LM, Grogan TM, Miller TP, LeBlanc M, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Connors JM, Lansdorp PM, Ouyang Q, Lister TA, Davies AJ, Norton AJ, Muller-Hermelink HK, Ott G, Campo E, Montserrat E, Wilson WH, Jaffe ES, Simon R, Yang L, Powell J, Zhao H, Goldschmidt N, Chiorazzi M, Staudt LM (2004)
   Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
   N Engl J Med, 351 (21), 2159-69
   PubMed 15548776
2. Fosså A, Alsøe L, Crameri R, Funderud S, Gaudernack G, Smeland EB (2004)
   Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display
   Cancer Immunol Immunother, 53 (5), 431-8
   PubMed 14747957
3. Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB (2004)
   NY-ESO-1 protein expression and humoral immune responses in prostate cancer
   Prostate, 59 (4), 440-7
   PubMed 15065093
4. Holm AM, Sivertsen EA, Tunheim SH, Haug T, Bjerkeli V, Yndestad A, Aukrust P, Frøland SS (2004)
   Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells
   Clin Exp Immunol, 138 (2), 278-89
   PubMed 15498038
5. Kersten C, Delabie J, Gaudernack G, Smeland EB, Fosså A (2004)
   Analysis of the autoantibody repertoire in Burkitt's lymphoma patients: frequent response against the transcription factor ATF-2
   Cancer Immunol Immunother, 53 (12), 1119-26
   PubMed 15185015
6. Moe JF, Sivertsen E, van Thanh D (2004)
   Adapting email functionality for mobile terminals
   LECT NOTE COMPUT SCI, 3283, 199-206
7. Sivertsen EA, Torfoss D (2004)
   [Cryptococcal meningitis]
   Tidsskr Nor Laegeforen, 124 (1), 28-30
   PubMed 14716388

Publications 2003

1. Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne RD, Chan WC, Zhao T, Haioun C, Greiner TC, Weisenburger DD, Lynch JC, Vose J, Armitage JO, Smeland EB, Kvaloy S, Holte H, Delabie J, Campo E, Montserrat E, Lopez-Guillermo A, Ott G, Muller-Hermelink HK, Connors JM, Braziel R, Grogan TM, Fisher RI, Miller TP, LeBlanc M, Chiorazzi M, Zhao H, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Staudt LM (2003)
   Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
   J Exp Med, 198 (6), 851-62
   PubMed 12975453
2. Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, Gascoyne RD, Grogan TM, Muller-Hermelink HK, Smeland EB, Chiorazzi M, Giltnane JM, Hurt EM, Zhao H, Averett L, Henrickson S, Yang L, Powell J, Wilson WH, Jaffe ES, Simon R, Klausner RD, Montserrat E, Bosch F, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Fisher RI, Miller TP, LeBlanc M, Ott G, Kvaloy S, Holte H, Delabie J, Staudt LM (2003)
   The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
   Cancer Cell, 3 (2), 185-97
   PubMed 12620412

Publications 2002

1. Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB (2002)
   Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells
   Exp Hematol, 30 (9), 990-1000
   PubMed 12225790
2. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, López-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T, Staudt LM, Lymphoma/Leukemia Molecular Profiling Project (2002)
   The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
   N Engl J Med, 346 (25), 1937-47
   PubMed 12075054
3. Wang J, Delabie J, Aasheim H, Smeland E, Myklebost O (2002)
   Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
   BMC Bioinformatics, 3, 36
   PubMed 12445336

Publications 2001

1. Blystad AK, Holte H, Kvaløy S, Smeland E, Delabie J, Kvalheim G (2001)
   High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
   Bone Marrow Transplant, 28 (9), 849-57
   PubMed 11781645
2. Hovig E, Myklebost O, Aamdal S, Smeland EB (2001)
   [Gene therapy in cancer]
   Tidsskr Nor Laegeforen, 121 (4), 482-8
   PubMed 11255868
3. Lyngstadaas A, Smeland EB (2001)
   [Gene therapy--status and recommendations in Norwegian health care system]
   Tidsskr Nor Laegeforen, 121 (3), 343-8
   PubMed 11242880
4. Stokke T, DeAngelis P, Smedshammer L, Galteland E, Steen HB, Smeland EB, Delabie J, Holte H (2001)
   Loss of chromosome 11q21-23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
   Br J Cancer, 85 (12), 1900-13
   PubMed 11747333

Publications 2000

1. Fosså A, Siebert R, Aasheim HC, Maelandsmo GM, Berner A, Fosså SD, Paus E, Smeland EB, Gaudernack G (2000)
   Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer
   Br J Cancer, 83 (6), 743-9
   PubMed 10952778
2. Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB (2000)
   Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
   Stem Cells, 18 (4), 261-72
   PubMed 10924092
3. Kissebah AH, Sonnenberg GE, Myklebust J, Goldstein M, Broman K, James RG, Marks JA, Krakower GR, Jacob HJ, Weber J, Martin L, Blangero J, Comuzzie AG (2000)
   Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome
   Proc Natl Acad Sci U S A, 97 (26), 14478-83
   PubMed 11121050
4. Myklebust JH, Smeland EB, Josefsen D, Sioud M (2000)
   Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow
   Blood, 95 (2), 510-8
   PubMed 10627456
5. Naderi S, Gützkow KB, Christoffersen J, Smeland EB, Blomhoff HK (2000)
   cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation
   Eur J Immunol, 30 (6), 1757-68
   PubMed 10898514
6. Stokke T, Galteland E, Holte H, Smedshammer L, Suo Z, Smeland EB, Børresen-Dale AL, DeAngelis P, Steen HB (2000)
   Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma
   Int J Cancer, 89 (4), 313-24
   PubMed 10956404
7. Aasheim HC, Munthe E, Funderud S, Smeland EB, Beiske K, Logtenberg T (2000)
   A splice variant of human ephrin-A4 encodes a soluble molecule that is secreted by activated human B lymphocytes
   Blood, 95 (1), 221-30
   PubMed 10607706

Publications 1999

1. Davidson B, Risberg B, Berner A, Smeland EB, Torlakovic E (1999)
   Evaluation of lymphoid cell populations in cytology specimens using flow cytometry and polymerase chain reaction
   Diagn Mol Pathol, 8 (4), 183-8
   PubMed 10617274
2. Fosså A, Brandhorst D, Myklebust JH, Seeber S, Nowrousian MR (1999)
   Relation between S-phase fraction of myeloma cells and anemia in patients with multiple myeloma
   Exp Hematol, 27 (11), 1621-6
   PubMed 10560909
3. Holte H, Suo Z, Smeland EB, Kvaløy S, Langholm R, Stokke T (1999)
   Prognostic value of lymphoma-specific S-phase fraction compared with that of other cell proliferation markers
   Acta Oncol, 38 (4), 495-503
   PubMed 10418718
4. Josefsen D, Blomhoff HK, Lømo J, Blystad AK, Smeland EB (1999)
   Retinoic acid induces apoptosis of human CD34+ hematopoietic progenitor cells: involvement of retinoic acid receptors and retinoid X receptors depends on lineage commitment of the hematopoietic progenitor cells
   Exp Hematol, 27 (4), 642-53
   PubMed 10210322
5. Josefsen D, Myklebust JH, Lynch DH, Stokke T, Blomhoff HK, Smeland EB (1999)
   Fas ligand promotes cell survival of immature human bone marrow CD34+CD38- hematopoietic progenitor cells by suppressing apoptosis
   Exp Hematol, 27 (9), 1451-9
   PubMed 10480436
6. Myklebust JH, Josefsen D, Blomhoff HK, Levy FO, Naderi S, Reed JC, Smeland EB (1999)
   Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression
   J Cell Physiol, 180 (1), 71-80
   PubMed 10362019
7. Naderi S, Blomhoff R, Myklebust J, Smeland EB, Erikstein B, Norum KR, Blomhoff HK (1999)
   Lovastatin inhibits G1/S transition of normal human B-lymphocytes independent of apoptosis
   Exp Cell Res, 252 (1), 144-53
   PubMed 10502407
8. Smeland E (1999)
   [University function at the central hospital in Akershus]
   Tidsskr Nor Laegeforen, 119 (11), 1647
   PubMed 10385812

Publications 1998

1. Aurlien E, Holte H, Pharo A, Kvaløy S, Jakobsen E, Smeland EB, Kvalheim G (1998)
   Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma
   Bone Marrow Transplant, 21 (9), 873-8
   PubMed 9613778
2. Heim S, Smeland EB (1998)
   [Molecular genetic diagnosis of leukemias and lymphomas]
   Tidsskr Nor Laegeforen, 118 (16), 2511-8
   PubMed 9667131
3. Ly B, Hammerstrøm J, Bergheim J, Dahl IM, Grøttum KA, Lødemel B, Baklien K, Smeland E (1998)
   [Chronic lymphatic leukemia. Immunophenotyping as an aid to correct diagnosis]
   Tidsskr Nor Laegeforen, 118 (2), 233-7
   PubMed 9485618
4. Lømo J, Smeland EB, Ulven S, Natarajan V, Blomhoff R, Gandhi U, Dawson MI, Blomhoff HK (1998)
   RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes
   J Cell Physiol, 175 (1), 68-77
   PubMed 9491782
5. Saeterdal I, thor Straten P, Myklebust JH, Kirkin AF, Gjertsen MK, Gaudernack G (1998)
   Generation and characterization of gp100 peptide-specific NK-T cell clones
   Int J Cancer, 75 (5), 794-803
   PubMed 9495251
6. Stokke T, Holte H, Smedshammer L, Smeland EB, Kaalhus O, Steen HB (1998)
   Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas
   Br J Cancer, 77 (11), 1832-8
   PubMed 9667654
7. Stokke T, Smeland EB, Kvaløy S, Holte H (1998)
   Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas
   Br J Cancer, 77 (11), 1839-41
   PubMed 9667655

Publications 1997

1. Blimke J, Volkmer H, Spilker M, Myklebust J (1997)
   Comparison of evoked potential source localization and functional MRI in a four-shell ellipsoidal volume conductor
   PROC ANN INT CONF IEEE EMBS, 19, 470-473
2. Gjertsen MK, Bjorheim J, Saeterdal I, Myklebust J, Gaudernack G (1997)
   Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
   Int J Cancer, 72 (5), 784-90
   PubMed 9311595
3. Hallan E, Blomhoff HK, Smeland EB, Lømo J (1997)
   Involvement of ICE (Caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes
   Scand J Immunol, 46 (6), 601-8
   PubMed 9420624
4. Halstead G, Myklebust J, Myklebust B (1997)
   Changes in voluntary reaction time with age: Implications for falls in the elderly
   PROC ANN INT CONF IEEE EMBS, 19, 1683-1685
5. Kvingedal AM, Smeland EB (1997)
   A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue
   FEBS Lett, 407 (1), 59-62
   PubMed 9141481
6. Lømo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB (1997)
   Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1
   Blood, 89 (12), 4415-24
   PubMed 9192766
7. Rasmussen AM, Horejsí V, Levy FO, Blomhoff HK, Smeland EB, Beiske K, Michaelsen TE, Gaudernack G, Funderud S (1997)
   CDw78--a determinant on a major histocompatibility complex class II subpopulation that can be induced to associate with the cytoskeleton
   Eur J Immunol, 27 (12), 3206-13
   PubMed 9464807
8. Smeland E (1997)
   [Changing physician's role]
   Tidsskr Nor Laegeforen, 117 (29), 4290
   PubMed 9441481
9. Aasheim HC, Pedeutour F, Smeland EB (1997)
   Characterization, expression and chromosomal localization of a human gene homologous to the mouse Lsc oncogene, with strongest expression in hematopoetic tissues
   Oncogene, 14 (14), 1747-52
   PubMed 9135076

Publications 1996

1. Jacobsen SE, Veiby OP, Myklebust J, Okkenhaug C, Lyman SD (1996)
   Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-beta and tumor necrosis factor-alpha
   Blood, 87 (12), 5016-26
   PubMed 8652814
2. Kvalheim G, Pharo A, Holte H, Jakobsen E, Erikstein B, Kvaløy S, Beiske K, Nesland JM, Smeland EB (1996)
   [High-dose therapy of cancer with CD34 positive cells as stem cell support]
   Tidsskr Nor Laegeforen, 116 (21), 2542-6
   PubMed 8928121
3. Kvalheim G, Wang MY, Pharo A, Holte H, Jacobsen E, Beiske K, Kvaløy S, Smeland E, Funderud S, Fodstad O (1996)
   Purging of tumor cells from leukapheresis products: experimental and clinical aspects
   J Hematother, 5 (4), 427-36
   PubMed 8877718
4. Levy FO, Rasmussen AM, Taskén K, Skålhegg BS, Huitfeldt HS, Funderud S, Smeland EB, Hansson V (1996)
   Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation
   Eur J Immunol, 26 (6), 1290-6
   PubMed 8647207
5. Lømo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK (1996)
   Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes
   Cancer Res, 56 (1), 40-3
   PubMed 8548771
6. Rusten LS, Dybedal I, Blomhoff HK, Blomhoff R, Smeland EB, Jacobsen SE (1996)
   The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells
   Blood, 87 (5), 1728-36
   PubMed 8634418
7. Røsok O, Odeberg J, Rode M, Stokke T, Funderud S, Smeland E, Lundeberg J (1996)
   Solid-phase method for differential display of genes expressed in hematopoietic stem cells
   Biotechniques, 21 (1), 114-21
   PubMed 8816245
8. Smeland E, Fuskevåg OM, Nymann K, Svendesn JS, Olsen R, Lindal S, Bremnes RM, Aarbakke J (1996)
   High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model
   Cancer Chemother Pharmacol, 37 (5), 415-22
   PubMed 8599863

Publications 1995

1. Deggerdal AH, Pettersen F, Kvalheim G, Hornes E, Smeland E, Fodstad O, Hovig E (1995)
   Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach
   Lab Invest, 72 (4), 411-8
   PubMed 7723279
2. FAHLMAN C, JACOBSEN SE, SMELAND EB, LOMO J, NAESS CE, FUNDERUD S, BLOMHOFF HK (1995)
   ALL-TRANS-RETINOIC AND 9-CIS-RETINOIC ACID INHIBIT GROWTH OF NORMAL HUMAN AND MURINE B-CELL PRECURSORS
   J. Immunol., 155 (1), 58-65
3. Fahlman C, Jacobsen SE, Smeland EB, Lømo J, Naess CE, Funderud S, Blomhoff HK (1995)
   All-trans- and 9-cis-retinoic acid inhibit growth of normal human and murine B cell precursors
   J Immunol, 155 (1), 58-65
   PubMed 7602122
4. Jacobsen SE, Okkenhaug C, Myklebust J, Veiby OP, Lyman SD (1995)
   The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors
   J Exp Med, 181 (4), 1357-63
   PubMed 7535335
5. Lømo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB (1995)
   TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes
   J Immunol, 154 (4), 1634-43
   PubMed 7836748
6. Smeland E (1995)
   [Physicians liable for military service for sale]
   Tidsskr Nor Laegeforen, 115 (24), 3072
   PubMed 7570542
7. Smeland E, Bremnes RM, Fuskevag OM, Aarbakke J (1995)
   The effect of calcium channel blockers and calcium on methotrexate accumulation in rat hepatocytes
   Anticancer Res, 15 (4), 1221-5
   PubMed 7654001
8. Smeland E, Bremnes RM, Fuskevåg OM, Aarbakke J (1995)
   Perturbation of methotrexate transport by verapamil, vinblastine, taurocholate and bromosulfophthalein in rat hepatocytes
   Anticancer Res, 15 (1), 45-50
   PubMed 7733639
9. Aas-Eng DA, Asheim HC, Deggerdal A, Smeland E, Funderud S (1995)
   Characterization of a promoter region supporting transcription of a novel human beta-galactoside alpha-2,6-sialyltransferase transcript in HepG2 cells
   Biochim Biophys Acta, 1261 (1), 166-9
   PubMed 7893756

Publications 1994

1. Christoffersen J, Smeland EB, Stokke T, Taskén K, Andersson KB, Blomhoff HK (1994)
   Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells
   Cancer Res, 54 (8), 2245-50
   PubMed 8174134
2. Jacobsen FW, Rothe M, Rusten L, Goeddel DV, Smeland EB, Veiby OP, Slørdal L, Jacobsen SE (1994)
   Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis
   Proc Natl Acad Sci U S A, 91 (22), 10695-9
   PubMed 7524102
3. Jacobsen SE, Fahlman C, Blomhoff HK, Okkenhaug C, Rusten LS, Smeland EB (1994)
   All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive murine hematopoietic progenitors in vitro
   J Exp Med, 179 (5), 1665-70
   PubMed 8163945
4. JACOBSEN SEW, FAHLMAN C, BLOMHOFF HK, OKKENHAUG C, RUSTEN LS, SMELAND EB (1994)
   ALL-TRANS-RETINOIC AND 9-CIS-RETINOIC ACID - POTENT DIRECT INHIBITORS OF PRIMITIVE MURINE HEMATOPOIETIC PROGENITORS IN-VITRO
   J. Exp. Med., 179 (5), 1665-1670
5. Kvalheim G, Jakobsen E, Holte H, Beiske K, Langholm R, Høiby A, Wang MY, Funderund S, Fodstad O, Smeland E (1994)
   Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads
   Prog Clin Biol Res, 389, 133-8
   PubMed 7700895
6. Kvaløy SO, Smeland EB (1994)
   [Bone marrow transplantation--a constantly developing procedure--requiring updating]
   Tidsskr Nor Laegeforen, 114 (3), 302-3
   PubMed 8191422
7. Rasmussen AM, Blomhoff HK, Stokke T, Horejsi V, Smeland EB (1994)
   Cross-linking of CD53 promotes activation of resting human B lymphocytes
   J Immunol, 153 (11), 4997-5007
   PubMed 7963560
8. Rusten LS, Jacobsen FW, Lesslauer W, Loetscher H, Smeland EB, Jacobsen SE (1994)
   Bifunctional effects of tumor necrosis factor alpha (TNF alpha) on the growth of mature and primitive human hematopoietic progenitor cells: involvement of p55 and p75 TNF receptors
   Blood, 83 (11), 3152-9
   PubMed 7514902
9. Rusten LS, Jacobsen SE, Kaalhus O, Veiby OP, Funderud S, Smeland EB (1994)
   Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells
   Blood, 84 (5), 1473-81
   PubMed 7520773
10. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SE (1994)
    Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors
    J Clin Invest, 94 (1), 165-72
    PubMed 7518828
11. Smeland E, Bremnes RM, Andersen A, Jaeger R, Eide TJ, Huseby NE, Aarbakke J (1994)
    Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat
    Cancer Chemother Pharmacol, 34 (2), 119-24
    PubMed 8194163
12. Smeland EB, Rusten L, Jacobsen SE, Skrede B, Blomhoff R, Wang MY, Funderud S, Kvalheim G, Blomhoff HK (1994)
    All-trans retinoic acid directly inhibits granulocyte colony-stimulating factor-induced proliferation of CD34+ human hematopoietic progenitor cells
    Blood, 84 (9), 2940-5
    PubMed 7524761
13. Aasheim HC, Deggerdal A, Smeland EB, Hornes E (1994)
    A simple subtraction method for the isolation of cell-specific genes using magnetic monodisperse polymer particles
    Biotechniques, 16 (4), 716-21
    PubMed 8024795
14. Aasheim HC, Loukianova T, Deggerdal A, Smeland EB (1994)
    Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K
    Nucleic Acids Res, 22 (6), 959-64
    PubMed 8152927

Publications 1993

1. Andersson KB, Deggerdal A, Skjønsberg C, Smeland EB, Blomhoff HK (1993)
   Constitutive expression of c-myc does not relieve cAMP-mediated growth arrest in human lymphoid Reh cells
   J Cell Physiol, 157 (1), 61-9
   PubMed 8408242
2. Erikstein BK, Holte H, Kvaløy S, Andersson KB, Steen HB, Hannisdal E, Smeland EB (1993)
   Expression of CD18 (integrin beta 2 chain) correlates with prognosis in malignant B cell lymphomas
   Br J Haematol, 83 (3), 392-8
   PubMed 8097923
3. Jacobsen SE, Veiby OP, Smeland EB (1993)
   Cytotoxic lymphocyte maturation factor (interleukin 12) is a synergistic growth factor for hematopoietic stem cells
   J Exp Med, 178 (2), 413-8
   PubMed 7688022
4. Slørdahl SH, Smeland EB, Holte H, Grønn M, Lie SO, Seip M (1993)
   Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia")
   Med Pediatr Oncol, 21 (4), 254-8
   PubMed 8469219
5. Smeland E, Bremnes RM, Bessesen A, Jaeger R, Aarbakke J (1993)
   Interactions of vinblastine and vincristine with methotrexate transport in isolated rat hepatocytes
   Cancer Chemother Pharmacol, 32 (3), 209-14
   PubMed 8500226
6. Aasheim HC, Aas-Eng DA, Deggerdal A, Blomhoff HK, Funderud S, Smeland EB (1993)
   Cell-specific expression of human beta-galactoside alpha 2,6-sialyltransferase transcripts differing in the 5' untranslated region
   Eur J Biochem, 213 (1), 467-75
   PubMed 8477718

Publications 1992

1. Blomhoff HK, Smeland EB, Erikstein B, Rasmussen AM, Skrede B, Skjønsberg C, Blomhoff R (1992)
   Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells
   J Biol Chem, 267 (33), 23988-92
   PubMed 1429735
2. Erikstein BK, Funderud S, Beiske K, Aas-Eng A, De Lange Davies C, Blomhoff HK, Smeland EB (1992)
   Cell cycle-dependent regulation of CDw75 (beta-galactoside alpha-2,6-sialyltransferase) on human B lymphocytes
   Eur J Immunol, 22 (5), 1149-55
   PubMed 1577059
3. Rasmussen AM, Smeland EB, Erikstein BK, Caignault L, Funderud S (1992)
   A new method for detachment of Dynabeads from positively selected B lymphocytes
   J Immunol Methods, 146 (2), 195-202
   PubMed 1371532
4. Smeland EB (1992)
   [Programmed cell death--significance for cancer etiology and treatment]
   Tidsskr Nor Laegeforen, 112 (12), 1567
   PubMed 1615504
5. Smeland EB, Beiske K (1992)
   [Immunophenotyping of leukemias]
   Tidsskr Nor Laegeforen, 112 (18), 2373-4
   PubMed 1412241
6. Smeland EB, Funderud S (1992)
   [Sugar molecules, cell adhesion and cancer etiology]
   Tidsskr Nor Laegeforen, 112 (22), 2834
   PubMed 1412318
7. SMELAND EB, FUNDERUD S, KVALHEIM G, EGELAND T (1992)
   EFFECTIVE ISOLATION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS - A NEW METHOD FOR DETACHMENT OF IMMUNOMAGNETIC BEADS FROM POSITIVELY SELECTED CD34+ CELLS
   INT J CELL CLONING, 10 Suppl 1, 108-110
8. Smeland EB, Funderud S, Kvalheim G, Gaudernack G, Rasmussen AM, Rusten L, Wang MY, Tindle RW, Blomhoff HK, Egeland T (1992)
   Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells
   Leukemia, 6 (8), 845-52
   PubMed 1379314
9. Smeland EB, Slørdal L (1992)
   [Cytokines--from research to clinical use]
   Tidsskr Nor Laegeforen, 112 (28), 3544
   PubMed 1462323
10. Stokke T, Holte H, Smeland EB, Lie SO, Steen HB (1992)
    Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells
    Cancer Res, 52 (18), 5007-12
    PubMed 1516056

Publications 1991

1. Bremnes RM, Smeland E, Huseby NE, Eide TJ, Aarbakke J (1991)
   Acute hepatotoxicity after high-dose methotrexate administration to rats
   Pharmacol Toxicol, 69 (2), 132-9
   PubMed 1775433
2. Bremnes RM, Smeland E, Slørdal L, Wist E, Aarbakke J (1991)
   The effect of vindesine on methotrexate hydroxylation in the rat
   Biochem Pharmacol, 42 (8), 1561-8
   PubMed 1930283
3. Bremnes RM, Smeland E, Willassen NP, Wist E, Aarbakke J (1991)
   Inhibition of 7-hydroxymethotrexate formation by amsacrine
   Cancer Chemother Pharmacol, 28 (5), 377-83
   PubMed 1914082
4. Erikstein BK, Schwarze P, Blomhoff HK, Funderud S, Stokke T, Smeland EB (1991)
   Use of size fractionation of in vitro-activated human B lymphocytes for studies of cell cycle-dependent growth regulation
   Scand J Immunol, 33 (1), 51-60
   PubMed 1899949
5. Erikstein BK, Smeland EB, Blomhoff HK, Funderud S, Prydz K, Lesslauer W, Espevik T (1991)
   Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes
   Eur J Immunol, 21 (4), 1033-7
   PubMed 1850359
6. Lømo J, Smeland EB, Stokke T, Holte H, Funderud S, Blomhoff HK (1991)
   Differential effects of interferon-gamma and low molecular weight BCGF on growth of human B lymphocytes; interferon-gamma prolongs the increased c-MYC mRNA levels after activation
   Scand J Immunol, 33 (4), 365-73
   PubMed 1902001
7. Naume B, Nonstad U, Steinkjer B, Funderud S, Smeland E, Espevik T (1991)
   Immunomagnetic isolation of NK and LAK cells
   J Immunol Methods, 136 (1), 1-9
   PubMed 1704900
8. Skjønsberg C, Erikstein BK, Smeland EB, Lie SO, Funderud S, Beiske K, Blomhoff HK (1991)
   Interleukin-7 differentiates a subgroup of acute lymphoblastic leukemias
   Blood, 77 (11), 2445-50
   PubMed 2039826
9. Skrede B, Blomhoff HK, Smeland EB, Wathne KO, Norum KR, Blomhoff R (1991)
   Retinyl esters in chylomicron remnants inhibit growth of myeloid and lymphoid leukaemic cells
   Eur J Clin Invest, 21 (6), 574-9
   PubMed 1778218

Publications 1990

1. Funderud S, Erikstein B, Asheim HC, Nustad K, Stokke T, Blomhoff HK, Holte H, Smeland EB (1990)
   Functional properties of CD19+ B lymphocytes positively selected from buffy coats by immunomagnetic separation
   Eur J Immunol, 20 (1), 201-6
   PubMed 1689662
2. Helgestad J, Pettersen R, Storm-Mathisen I, Schjerven L, Ulrich K, Smeland EB, Egeland T, Sørskaard D, Brøgger A, Hovig T (1990)
   Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid
   Eur J Haematol, 44 (1), 9-17
   PubMed 2307225
3. Schøyen H, Iversen JG, Smeland EB, Heikkilä R (1990)
   A transient acidification linked to intracellular Ca2+ in anti-mu-stimulated human B-lymphocytes
   Acta Physiol Scand, 138 (2), 221-7
   PubMed 1690498
4. Skjønsberg C, Kiil Blomhoff H, Gaudernack G, Funderud S, Beiske K, Smeland EB (1990)
   Immunological typing of acute leukaemias by rosetting with immunomagnetic beads: comparison with immunofluorescence staining
   Scand J Immunol, 31 (5), 567-73
   PubMed 2189214
5. Smeland EB, Holte H, Kiil Blomhoff H, Asheim HC, Stokke T, Torjesen P, Funderud S (1990)
   Inhibition of polyphosphoinositide breakdown and c-myc induction accompanying inhibition of human B-cell activation by two monoclonal antibodies against the leucocyte common antigen (CD45)
   Scand J Immunol, 31 (5), 583-91
   PubMed 1693226
6. Stamenkovic I, Asheim HC, Deggerdal A, Blomhoff HK, Smeland EB, Funderud S (1990)
   The B cell antigen CD75 is a cell surface sialytransferase
   J Exp Med, 172 (2), 641-3
   PubMed 2373995

Publications 1989

1. Brinch L, Evensen SA, Stavem P, Smeland EB (1989)
   [Experiences of immunologic phenotyping in acute leukemia]
   Tidsskr Nor Laegeforen, 109 (4), 443-6
   PubMed 2919374
2. Børresen AL, Brøgger A, Møller P, Smeland E (1989)
   [Gene technology in the prevention of cancer]
   Tidsskr Nor Laegeforen, 109 (33), 3430-4
   PubMed 2609305
3. Holte H, Blomhoff HK, Beiske K, Funderud S, Torjesen P, Gaudernack G, Stokke T, Smeland EB (1989)
   Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens
   Eur J Immunol, 19 (7), 1221-5
   PubMed 2547623
4. Holte H, de Lange Davies C, Beiske K, Stokke T, Marton PF, Smeland EB, Høie J, Kvaløy S (1989)
   Ki67 and 4F2 antigen expression as well as DNA synthesis predict survival at relapse/tumour progression in low-grade B-cell lymphoma
   Int J Cancer, 44 (6), 975-80
   PubMed 2606582
5. Holte H, Stokke T, Smeland E, Watt R, Blomhoff HK, Kaalhus O, Ohlsson R (1989)
   Levels of myc protein, as analyzed by flow cytometry, correlate with cell growth potential in malignant B-cell lymphomas
   Int J Cancer, 43 (1), 164-70
   PubMed 2642893
6. Smeland EB, Blomhoff HK, Funderud S, Shalaby MR, Espevik T (1989)
   Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes
   J Exp Med, 170 (4), 1463-8
   PubMed 2677211
7. Smeland EB, Godal T (1989)
   [The 1989 Nobel Prize in physiology and medicine]
   Tidsskr Nor Laegeforen, 109 (34-36), 3541-2
   PubMed 2694425

Publications 1988

1. Beiske K, Clark EA, Holte H, Ledbetter JA, Smeland EB, Godal T (1988)
   Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets
   Int J Cancer, 42 (4), 521-8
   PubMed 2459071
2. Blomhoff HK, Blomhoff R, Stokke T, deLange Davies C, Brevik K, Smeland EB, Funderud S, Godal T (1988)
   cAMP-mediated growth inhibition of a B-lymphoid precursor cell line Reh is associated with an early transient delay in G2/M, followed by an accumulation of cells in G1
   J Cell Physiol, 137 (3), 583-7
   PubMed 2848044
3. Holte H, Torjesen P, Blomhoff HK, Ruud E, Funderud S, Smeland EB (1988)
   Cyclic AMP has the ability to influence multiple events during B cell stimulation
   Eur J Immunol, 18 (9), 1359-66
   PubMed 2458941
4. Smeland EB (1988)
   [The immunoglobulin gene superfamily]
   Tidsskr Nor Laegeforen, 108 (13), 1029-32, 1004
   PubMed 2455362
5. Smeland EB (1988)
   [Cellular oncogenes. Role in normal cell growth and activation in neoplasms]
   Tidsskr Nor Laegeforen, 108 (16), 1299-303
   PubMed 3291192
6. Smeland EB, Blomhoff HK, Ohlsson R, De Lange Davies C, Funderud S, Boye E (1988)
   Transcription of protooncogenes during stimulation of normal human B lymphocytes
   Eur J Immunol, 18 (11), 1847-50
   PubMed 3060364
7. Wathne KO, Norum KR, Smeland E, Blomhoff R (1988)
   Retinol bound to physiological carrier molecules regulates growth and differentiation of myeloid leukemic cells
   J Biol Chem, 263 (18), 8691-5
   PubMed 3163997

Publications 1987

1. Blomhoff HK, Smeland E, Mustafa AS, Godal T, Ohlsson R (1987)
   Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage
   Eur J Immunol, 17 (2), 299-301
   PubMed 3030769
2. Blomhoff HK, Smeland EB, Beiske K, Blomhoff R, Ruud E, Bjøro T, Pfeifer-Ohlsson S, Watt R, Funderud S, Godal T (1987)
   Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes
   J Cell Physiol, 131 (3), 426-33
   PubMed 3036888
3. Holte H, Davies CD, Kvaløy S, Smeland EB, Foss-Abrahamsen A, Kaalhus O, Marton PF, Godal T (1987)
   The activation-associated antigen 4F2 predicts patient survival in low-grade B-cell lymphomas
   Int J Cancer, 39 (5), 590-4
   PubMed 3106247
4. Lømo J, Holte H, de Lange Davies C, Ruud E, Laukas M, Smeland EB, Godal T, Blomhoff HK (1987)
   Downregulation of c-myc RNA is not a prerequisite for reduced cell proliferation, but is associated with G1 arrest in B-lymphoid cell lines
   Exp Cell Res, 172 (1), 84-91
   PubMed 3115797
5. Smeland EB, Beiske K, Ek B, Watt R, Pfeifer-Ohlsson S, Blomhoff HK, Godal T, Ohlsson R (1987)
   Regulation of c-myc transcription and protein expression during activation of normal human B cells
   Exp Cell Res, 172 (1), 101-9
   PubMed 3308492
6. Smeland EB, Beiske K, Ohlsson R, Holte H, Ruud E, Blomhoff HK, Jefferis R, Godal T (1987)
   Activation of human B cells: alternate options for initial triggering and effects of nonmitogenic concentrations of anti-IgM antibodies on resting and activated cells
   J Immunol, 138 (10), 3179-84
   PubMed 3553323
7. Smeland EB, Blomhoff HK, Holte H, Ruud E, Beiske K, Funderud S, Godal T, Ohlsson R (1987)
   Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes
   Exp Cell Res, 171 (1), 213-22
   PubMed 2442015

Publications 1986

1. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O (1986)
   Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study
   Br Med J (Clin Res Ed), 293 (6556), 1195-9
   PubMed 3096429
2. Lea T, Smeland E, Funderud S, Vartdal F, Davies C, Beiske K, Ugelstad J (1986)
   Characterization of human mononuclear cells after positive selection with immunomagnetic particles
   Scand J Immunol, 23 (4), 509-19
   PubMed 2422741
3. Smeland EB, Godal T (1986)
   IgG subclasses in lymphomas
   Monogr Allergy, 19, 164-8
   PubMed 3762542
4. Smeland EB, Godal T, Beiske K, Watt R, Pfeifer-Ohlsson S, Ohlsson R (1986)
   Regulation of c-myc mRNA and protein levels during activation of normal human B cells
   Curr Top Microbiol Immunol, 132, 290-6
   PubMed 3539537

Publications 1985

1. Andersen HT, Smeland EB, Owe JO, Myhre K (1985)
   Analyses of maximum cardiopulmonary performance during exposure to acute hypoxia at simulated altitude--sea level to 5000 meters (760-404 mm Hg)
   Aviat Space Environ Med, 56 (12), 1192-7
   PubMed 4084174
2. Godal T, Davies C, Smeland EB, Heikkilä R, Funderud S, Steen HB, Hildrum K (1985)
   Antibodies to surface IgM and IgD increase the expression of various class II antigens on human B cells
   Eur J Immunol, 15 (2), 173-7
   PubMed 3871699
3. Heikkilä R, Iversen JG, Smeland E, Godal T (1985)
   Intracellular Ca2+ buffering potentiates an 86Rb+ permeability response in human lymphocytes
   Acta Physiol Scand, 124 (2), 247-51
   PubMed 3925725
4. Smeland E, Funderud S, Ruud E, Kiil Blomhoff H, Godal T (1985)
   Characterization of two murine monoclonal antibodies reactive with human B cells. Their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor
   Scand J Immunol, 21 (3), 205-14
   PubMed 3887557
5. Smeland E, Godal T, Ruud E, Beiske K, Funderud S, Clark EA, Pfeifer-Ohlsson S, Ohlsson R (1985)
   The specific induction of myc protooncogene expression in normal human B cells is not a sufficient event for acquisition of competence to proliferate
   Proc Natl Acad Sci U S A, 82 (18), 6255-9
   PubMed 3929253

Publications 1984

1. Bjøro T, Gaarder PI, Smeland EB, Kornstad L (1984)
   Thyroid antibodies in blood donors: prevalence and clinical significance
   Acta Endocrinol (Copenh), 105 (3), 324-9
   PubMed 6702401
2. Smeland EB, Jefferis R, Godal T (1984)
   Surface IgG subclasses in human B cell lymphomas as revealed by monoclonal antibodies
   Clin Exp Immunol, 57 (1), 163-70
   PubMed 6378459
3. Smeland EB, Owe JO, Andersen HT (1984)
   Modification of the 'dividing bradycardia' by hypoxia or exercise
   Respir Physiol, 56 (2), 245-51
   PubMed 6463431